Puma Biotechnology (PBYI) Gross Margin (QoQ) (2017 - 2026)

Puma Biotechnology (PBYI) Gross Margin (QoQ) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Puma Biotechnology 407.27 Mn 368.99 Mn 34.39 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 739.00
Dec 31, 2025 -830.00
Sep 30, 2025 111.00
Jun 30, 2025 -51.00
Mar 31, 2025 62.00
Dec 31, 2024 1,256.00
Sep 30, 2024 -1,349.00
Jun 30, 2024 188.00
Mar 31, 2024 919.00
Dec 31, 2023 -1,003.00
Sep 30, 2023 -194.00
Jun 30, 2023 332.00
Mar 31, 2023 -584.00
Dec 31, 2022 267.00
Sep 30, 2022 318.00
Jun 30, 2022 -135.00
Mar 31, 2022 -222.00
Dec 31, 2021 74.00
Sep 30, 2021 19.00
Jun 30, 2021 769.00